0000899243-21-021292.txt : 20210601 0000899243-21-021292.hdr.sgml : 20210601 20210601160549 ACCESSION NUMBER: 0000899243-21-021292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210530 FILED AS OF DATE: 20210601 DATE AS OF CHANGE: 20210601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mitchener Stephen CENTRAL INDEX KEY: 0001774519 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 21985260 MAIL ADDRESS: STREET 1: C/O AXCELLA HEALTH INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-30 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001774519 Mitchener Stephen C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459 0 1 0 0 SVP, Chief Business Officer Common Stock 2021-05-30 4 M 0 1500 A 3000 D Restricted Stock Units 2021-05-30 4 M 0 1500 0.00 D Common Stock 1500 1500 D Restricted stock units ("RSUs") convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The reporting person has reported a prior award of 3,000 RSUs (described in footnote 3 below) in Table II of Form 4. The total reported in Column 5 includes 1,500 RSUs previously reported in Table II and 1,500 shares of common stock. On November 30, 2020, the reporting person was granted 3,000 RSUs, which vested as to 50% of the shares on May 30, 2021, with the remaining 50% vesting on November 30, 2021. 1,500 of the RSUs vested on May 30, 2021. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date. /s/ Nancy Smith as Attorney-in-Fact for Stephen Mitchener 2021-06-01